Overview of Molecular Testing of Cytology Specimens

Objective: Utilizing cytology specimens for molecular testing has attracted increasing attention in the era of personalized medicine. Cytology specimens are clinically easier to access. The samples can be quickly and completely fixed in a very short time of fixation before tissue degradation occurs, compared to hours or days of fixation in surgical pathology specimens. In addition, cytology specimens can be fixed without formalin, which can significantly damage DNA and RNA. All these factors contribute to the superb quality of DNA and RNA in cytology specimens for molecular tests. Study Design: We summarize the most pertinent information in the literature regarding molecular testing in the field of cytopathology. Results: The first part focuses on the types of cytological specimens that can be used for molecular testing, including the advantages and limitations. The second section describes the common molecular tests and their clinical application. Conclusion: Various types of cytology specimens are suitable for many molecular tests, which may require additional clinical laboratory validation.

• Publication year

  2019

• Venue

  Acta Cytologica

• Publication date

  2019-03-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000497187PMID 30917368
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Next generation sequencing-based molecular profiling of lung adenocarcinoma using pleural effusion specimens.

  2018cited by this paper
• Molecular Pathology Techniques: Advances in 2018.

  2018cited by this paper
• Cytology Smears in the Era of Molecular Biomarkers in Non-Small Cell Lung Cancer: Doing More With Less.

  2018cited by this paper
• Molecular Pathology of Lung Cancer Cytology Specimens: A Concise Review.

  2018cited by this paper
• Cytological preparations for molecular analysis: A review of technical procedures, advantages and limitations for referring samples for testing

  2018cited by this paper
• Cost‐effectiveness of lobectomy versus genetic testing (Afirma®) for indeterminate thyroid nodules: Considering the costs of surveillance

  2018cited by this paper
• Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling

  2018cited by this paper
• Molecular Tests Use in Cytological Material (Analytical Phase)

  2018cited by this paper
• Next‐generation sequencing of cytologic preparations: An analysis of quality metrics

  2017cited by this paper
• Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK‐Positive NSCLC With Disease Progression During Crizotinib Treatment

  2017cited by this paper
• Liquid biopsies come of age: towards implementation of circulating tumour DNA

  2017cited by this paper
• Next-Generation Sequencing Identifies Gene Mutations That Are Predictive of Malignancy in Residual Needle Rinses Collected From Fine-Needle Aspirations of Thyroid Nodules.

  2017cited by this paper
• Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma.

  2017cited by this paper
• Circulating tumor cells and DNA for real-time EGFR detection and monitoring of non-small-cell lung cancer.

  2017cited by this paper
• Novel Modification of HistoGel-Based Cell Block Preparation Method: Improved Sufficiency for Molecular Studies.

  2017cited by this paper
• Detection of BRAF mutation in the cytocentrifugation supernatant fluid from fine-needle aspiration of thyroid lesions may enhance the diagnostic yield

  2017cited by this paper
• Next‐generation sequencing of liquid‐based cytology non–small cell lung cancer samples

  2017cited by this paper
• EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study.

  2017cited by this paper
• Evaluation of the Afirma Gene Expression Classifier in Repeat Indeterminate Thyroid Nodules.

  2017cited by this paper
• EGFR mutation testing using archival‐stained smears in non‐small cell lung carcinoma

  2017cited by this paper
• Utilization of direct smears of thyroid fine‐needle aspirates for ancillary molecular testing: A comparison of two proprietary testing platforms

  2017cited by this paper
• Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes

  2017cited by this paper
• Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisions

  2017cited by this paper
• Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid Malignancies.

  2016cited by this paper
• The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genes

  2016cited by this paper
• Optimizing the DNA yield for molecular analysis from cytologic preparations

  2016cited by this paper
• Detection of the T790M mutation of EGFR in plasma of advanced non–small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors (West Japan oncology group 8014LTR study)

  2016cited by this paper
• The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics.

  2016cited by this paper
• ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study

  2016cited by this paper
• Detection of the T 790 M mutation of EGFR in plasma of advanced non – small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors ( West Japan oncology group 8014 LTR study )

  2016cited by this paper
• Molecular Pathology Methods

  2016cited by this paper
• Molecular Techniques and Methods Applied in Cytology

  2016cited by this paper
• Gene Expression Classifier Testing and the Surgical Decision-Making Process for Patients With Thyroid Nodules.

  2016cited by this paper
• Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer

  2016cited by this paper
• Destaining of Diff-Quik stained cytologic smears is not necessary for the detection of anaplastic lymphoma kinase gene rearrangement in lung adenocarcinoma by fluorescence in situ hybridization

  2016cited by this paper
• Clinical Utility of Circulating Tumor DNA for Molecular Assessment and Precision Medicine in Pancreatic Cancer.

  2016cited by this paper
• A comparative study of EGFR oncogenic mutations in matching tissue and plasma samples from patients with advanced non-small cell lung carcinoma.

  2016cited by this paper
• Cytology Specimens: A Goldmine for Molecular Testing.

  2016cited by this paper
• Cell block samples from endobronchial ultrasound transbronchial needle aspiration provide sufficient material for ancillary testing in lung cancer-a quaternary referral centre experience.

  2016cited by this paper
• Origins, structures, and functions of circulating DNA in oncology

  2016cited by this paper
• Using “residual” FNA rinse and body fluid specimens for next‐generation sequencing: An institutional experience

  2016cited by this paper
• Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.

  2016cited by this paper
• Evaluation of RNA and DNA extraction from liquid‐based cytology specimens

  2016cited by this paper
• Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin.

  2016cited by this paper
• Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology

  2015cited by this paper
• Evaluation of the Real-Q BRAF V600E Detection Assay in Fine-Needle Aspiration Samples of Thyroid Nodules.

  2015cited by this paper
• Detection of ALK rearrangements in malignant pleural effusion cell blocks from patients with advanced non‐small cell lung cancer: A comparison of Ventana immunohistochemistry and fluorescence in situ hybridization

  2015cited by this paper
• EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291.

  2015cited by this paper
• Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies

  2015cited by this paper
• Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers

  2015cited by this paper
• Poor cell block adequacy rate for molecular testing improved with the addition of Diff‐Quik–stained smears: Need for better cell block processing

  2015cited by this paper
• Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas.

  2015cited by this paper
• ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non‐small cell lung cancer patients

  2015cited by this paper
• Challenges and opportunities of next‐generation sequencing: a cytopathologist's perspective

  2015cited by this paper
• Molecular markers: Implications for cytopathology and specimen collection

  2015cited by this paper
• Wide Inter-institutional Variation in Performance of a Molecular Classifier for Indeterminate Thyroid Nodules

  2015cited by this paper
• Multiplatform comparison of molecular oncology tests performed on cytology specimens and formalin‐fixed, paraffin‐embedded tissue

  2015cited by this paper
• A DNA real-time quantitative PCR method suitable for routine monitoring of low levels of minimal residual disease in chronic myeloid leukemia.

  2015cited by this paper
• Use of FTA cards for the storage of breast carcinoma nucleic acid on fine‐needle aspiration samples

  2015cited by this paper
• Multiplex sequencing for EZH2, CD79B, and MYD88 mutations using archival cytospin preparations from B‐cell non‐Hodgkin lymphoma aspirates previously tested for MYC rearrangement and IGH/BCL2 translocation

  2015cited by this paper
• Dynamic Plasma EGFR Mutation Status as a Predictor of EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Adenocarcinoma

  2015cited by this paper
• Cytology specimens offer an effective alternative to formalin‐fixed tissue as demonstrated by novel automated detection for ALK break‐apart FISH testing and immunohistochemistry in lung adenocarcinoma

  2014cited by this paper
• Clinical Utility of a Blood-Based BRAFV600E Mutation Assay in Melanoma

  2014cited by this paper
• Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond

  2014cited by this paper
• Analytical validation of BRAF mutation testing from circulating free DNA using the amplification refractory mutation testing system.

  2014cited by this paper
• An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.

  2014cited by this paper
• The value of mutational profiling of the cytocentrifugation supernatant fluid from fine-needle aspiration of pancreatic solid mass lesions

  2014cited by this paper
• Predictive factors in patients with EGFR mutation-negative non-small cell lung cancer treated with erlotinib

  2014cited by this paper
• ALK Status Testing in Non–Small-Cell Lung Carcinoma by FISH on ThinPrep Slides with Cytology Material

  2014cited by this paper
• Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assay

  2014cited by this paper
• Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA

  2014cited by this paper
• EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC).

  2014cited by this paper
• Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer

  2014cited by this paper
• Transbronchial Biopsy Needle Rinse Solution Used for Comprehensive Biomarker Testing in Patients with Lung Cancer

  2014cited by this paper
• Detection of BRAF Mutation in Metastatic Melanoma Utilizing Cell-Transferred Cytological Smears

  2014cited by this paper
• The state of cell block variation and satisfaction in the era of molecular diagnostics and personalized medicine

  2014cited by this paper
• Gefitinib Treatment in EGFR Mutated Caucasian NSCLC

  2014cited by this paper
• Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA

  2014cited by this paper
• Acquired resistance to EGFR‐targeted therapies in colorectal cancer

  2014cited by this paper
• Abstract 5606: Detection of circulating tumor DNA in early and late stage human malignancies

  2014cited by this paper
• Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma.

  2014cited by this paper
• Ancillary techniques on direct‐smear aspirate slides: A significant evolution for cytopathology techniques

  2013cited by this paper
• Ancillary techniques on direct‐smear aspirate slides

  2013cited by this paper
• Molecular pathology techniques.

  2013cited by this paper
• Preparation of DNA from cytological material

  2013cited by this paper
• Molecular Profiling of Thin-Prep FNA Samples in Assisting Clinical Management of Non-Small-Cell Lung Cancer

  2013cited by this paper
• Analysis of circulating tumor DNA to monitor metastatic breast cancer.

  2013cited by this paper
• ALK rearrangements in EBUS‐derived transbronchial needle aspiration cytology in lung cancer

  2013cited by this paper
• A Comparison of Methods for EGFR Mutation Testing in Non–Small Cell Lung Cancer

  2013cited by this paper
• Next-Generation Sequencing of Lung Cancer EGFR Exons 18-21 Allows Effective Molecular Diagnosis of Small Routine Samples (Cytology and Biopsy)

  2013cited by this paper
• Mutational analysis of cytocentrifugation supernatant fluid from pancreatic solid mass lesions

  2013cited by this paper
• Improvement of cellularity on cell block preparations using the so‐called tissue coagulum clot method during endobronchial ultrasound‐guided transbronchial fine‐needle aspiration

  2012cited by this paper
• Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer.

  2012cited by this paper
• Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood

  2012cited by this paper
• Optimized algorithm for Sanger sequencing-based EGFR mutation analyses in NSCLC biopsies

  2012cited by this paper
• The use of FTA cards for preserving unfixed cytological material for high‐throughput molecular analysis

  2012cited by this paper
• Allele Specific Locked Nucleic Acid Quantitative PCR (ASLNAqPCR): An Accurate and Cost-Effective Assay to Diagnose and Quantify KRAS and BRAF Mutation

  2012cited by this paper
• Molecular Analysis of Centrifugation Supernatant Fluid from Pancreaticobiliary Duct Samples Can Improve Cancer Detection

  2012cited by this paper
• Microspread ovarian cell preparations for the analysis of meiotic prophase progression in oocytes with improved recovery by cytospin centrifugation.

  2012cited by this paper
• KRAS Detection in Colonic Tumors by DNA Extraction From FTA Paper: The Molecular Touch-Prep

  2011cited by this paper

• Choice of fixative affects programmed death‐ligand 1 expression in cell blocks from pleural effusions with metastatic pulmonary adenocarcinoma

  2026cites this paper
• Evaluating the Impact of Sample Volume on Cytological Diagnosis of Pleural Effusion: A Single-Institution Study Using the International System for Reporting Serous Fluid Cytopathology.

  2025cites this paper
• Next-Generation Approaches to Improve the Information Content of Interventional Radiology Biopsies.

  2025cites this paper
• Utility of a Novel High‐Sensitivity Multiplex Companion Diagnostic Test Using Formalin‐Fixed Paraffin‐Embedded Cell Block Materials of Non‐small Cell Lung Cancer

  2025cites this paper
• A novel rotation and scale-invariant deep learning framework leveraging conical transformers for precise differentiation between meningioma and solitary fibrous tumor

  2025cites this paper
• Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers

  2025cites this paper
• Molecular cytopathology: The future of pathology?

  2025cites this paper
• From microscopes to molecules: The evolution of prostate cancer diagnostics

  2024cites this paper
• Minimally Invasive, Maximally Effective: The Power of Precision Cytoanalysis on Effusion Samples-A Comprehensive Exploration from Traditional Methods to Innovative Approaches.

  2024cites this paper
• The impact of different fixatives on immunostaining of lung adenocarcinomas in pleural effusion cell blocks

  2024cites this paper
• Comprehensive Genomic Studies on the Cell Blocks of Pancreatic Cancer

  2024cites this paper
• The World Health Organization Reporting System for Lung Cytopathology–A Review of the First Edition

  2024cites this paper
• Combined Use of Cell Block and Smear Improves the Cytological Diagnosis of Malignancy in Non-Palpable Breast Lesions Screened by Imaging

  2023cites this paper
• Telecytology rapid onsite evaluation, with real-time communication between cytopathologist, cytotechnologist, and proceduralist, offers better adequacy rates for lymph node, but not thyroid, fine-needle aspirations.

  2023cites this paper
• Pre‐analytical effects on whole transcriptome and targeted RNA sequencing analysis in cytology: The effects of prolonged time in storage of effusion specimens prior to preservation

  2023cites this paper
• Doing more with less: multiple uses of a single slide in veterinary cytology. A practical approach

  2022cites this paper
• Diagnostic Approach According to Uncovered Metastatic Sites: Mediastinum-Thymus, Peritoneum, Central Nervous System, and Soft Tissue

  2022cites this paper
• Tissue Microarray from Cell Block Material (cbTMA)—An Additional Shot for Cytology in the Predictive Pathology Era: The PD-L1 Experience

  2022cites this paper
• Role of Pathologist in the Era of Image-Guided and EUS-Guided Aspirations: A 10-Year Study at a Single Tertiary Care Oncology Institute in North India

  2022cites this paper
• Optimal Preservations of Cytological Materials Using Liquid-Based Cytology Fixatives for Next-Generation Sequencing Analysis

  2022cites this paper
• Molecular Diagnostics of Lung Cancer in Serous Effusion Samples

  2022cites this paper
• Cell block‐based RNA next generation sequencing for detection of gene fusions in lung adenocarcinoma: An institutional experience

  2022cites this paper
• Geographic Distribution, Number, and Types of Papers Published in International Cytopathology Journals in the Last 5.5 Years: A Perspective from India

  2022cites this paper
• The basics of commonly used molecular techniques for diagnosis, and application of molecular testing in cytology

  2022cites this paper
• Biomarker testing of cytology specimens in personalized medicine for lung cancer patients

  2022cites this paper
• BOC‐PLAG1, a new fusion gene of pleomorphic adenoma: Identified in a fine‐needle aspirate by RNA next‐generation sequencing

  2021cites this paper
• ATR-Spin: an open-source 3D printed device for direct cytocentrifugation onto attenuated total reflectance crystals.

  2021cites this paper
• Factors Influencing Concordance of PD-L1 Expression between Biopsies and Cytological Specimens in Non-Small Cell Lung Cancer

  2021cites this paper
• Evaluation of Cytologic Sample Preparations for Compatibility With Nucleic Acid Analysis

  2021cites this paper
• EGFR analysis on scrapings from cytology smears in lung carcinoma, an effective alternative to testing on trucut biopsies

  2021cites this paper
• Multigene Combined Detection by RT-qPCR Using Cytological Specimens

  2021cites this paper
• Molecular cytology of the respiratory tract and pleura

  2021cites this paper
• Clinical Application of Chromosome Microarray Analysis in the Diagnosis of Lipomatous Tumors

  2021cites this paper
• Results from the 2019 American Society of Cytopathology survey on rapid onsite evaluation (ROSE)-part 2: subjective views among the cytopathology community.

  2020cites this paper
• Molecular evaluation of a multiplex methylation panel for epigenetic analysis of FNAB samples from Greek patients with suspicious breast lesions.

  2020cites this paper
• Molecular Profiling of Malignant Pleural Effusions with Next Generation Sequencing (NGS): Evidence that Supports Its Role in Cancer Management

  2020cites this paper
• Diagnostic accuracy of molecular testing with three molecular markers on thyroid fine‐needle aspiration cytology with abnormal category

  2020cites this paper
• Cytopathology Comes of Age

  2019cites this paper
• Clinical application of RNA sequencing in sarcoma diagnosis

  2019cites this paper